Lupin to buy Gavis Pharmaceuticals
MLex Summary: Pharmaceuticals company Lupin Limited, based in Mubai, India, has agreed to buy Gavis Pharmaceuticals for $880 million. Statement follows in full: ...To view the full article, register now.
Already a subscriber? Click here to view full article